230 related articles for article (PubMed ID: 22587637)
21. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
Nübling CM; Daas A; Buchheit KH
Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
[TBL] [Abstract][Full Text] [Related]
22. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
[TBL] [Abstract][Full Text] [Related]
24. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Ma L; Padley DJ; Heath AB; Yu MW;
Vox Sang; 2012 Apr; 102(3):204-11. PubMed ID: 21988191
[TBL] [Abstract][Full Text] [Related]
25. Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020.
Drews SJ; Charlton C; O'Brien SF; Burugu S; Denomme GA
Vox Sang; 2024 Jun; 119(6):624-629. PubMed ID: 38482941
[TBL] [Abstract][Full Text] [Related]
26. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
27. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
PeerJ; 2023; 11():e15698. PubMed ID: 37554334
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of hepatitis B virus DNA in plasma using a sensitive cost-effective "in-house" real-time PCR assay.
Daniel HD; Fletcher JG; Chandy GM; Abraham P
Indian J Med Microbiol; 2009; 27(2):111-5. PubMed ID: 19384032
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
Ronsin C; Pillet A; Bali C; Denoyel GA
J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
[TBL] [Abstract][Full Text] [Related]
33. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England.
Williams S; Ratcliff J; Nguyen D; Simmonds P; Harvala H;
Transfus Med; 2022 Oct; 32(5):402-409. PubMed ID: 35751630
[TBL] [Abstract][Full Text] [Related]
34. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
Phikulsod S; Oota S; Tirawatnapong T; Sakuldamrongpanich T; Chalermchan W; Louisirirotchanakul S; Tanprasert S; Chongkolwatana V; Kitpoka P; Phanuphak P; Wasi C; Nuchprayoon C;
Transfusion; 2009 Jun; 49(6):1126-35. PubMed ID: 19392770
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.
Modrow S; Wenzel JJ; Schimanski S; Schwarzbeck J; Rothe U; Oldenburg J; Jilg W; Eis-Hübinger AM
Vox Sang; 2011 May; 100(4):351-8. PubMed ID: 21133933
[TBL] [Abstract][Full Text] [Related]
36. A new quantitative PCR for human parvovirus B19 genotypes.
Toppinen M; Norja P; Aaltonen LM; Wessberg S; Hedman L; Söderlund-Venermo M; Hedman K
J Virol Methods; 2015 Jun; 218():40-5. PubMed ID: 25794796
[TBL] [Abstract][Full Text] [Related]
37. Inactivation and neutralization of parvovirus B19 Genotype 3.
Blümel J; Rinckel LA; Lee DC; Roth NJ; Baylis SA
Transfusion; 2012 Jul; 52(7):1490-7. PubMed ID: 22339291
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
Thomas I; Di Giambattista M; Gérard C; Mathys E; Hougardy V; Latour B; Branckaert T; Laub R
Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
[TBL] [Abstract][Full Text] [Related]
39. [Detection of B19 parvovirus in plasma pools before solvent-detergent treatment of plasma: AFSSAPS and EFS Aquitaine-Limousin's experience].
Petermann R; Piquet Y; Lapeyre M; Goujon N; Gauthier M; Lalanne V; Mouillot L; Tissier MH; Boiron JM
Transfus Clin Biol; 2010 Apr; 17(2):54-62. PubMed ID: 20674438
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
